385 related articles for article (PubMed ID: 31960741)
1. Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies.
Biersmith MA; Tong MS; Guha A; Simonetti OP; Addison D
J Am Heart Assoc; 2020 Jan; 9(2):e013755. PubMed ID: 31960741
[No Abstract] [Full Text] [Related]
2. Cardio-oncology: Clinical and imaging perspectives for optimal cardiodetection and cardioprotection in patients with cancer.
Thuny F; Huttin O; Ederhy S
Arch Cardiovasc Dis; 2019 Oct; 112(10):550-558. PubMed ID: 31522992
[No Abstract] [Full Text] [Related]
3. The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics.
Agha A; Zarifa A; Kim P; Iliescu C; Gladish G; Hassan S; Palaskas N; Durand JB; Lu Y; Lopez-Mattei J
Methodist Debakey Cardiovasc J; 2019; 15(4):258-266. PubMed ID: 31988686
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Magnetic Resonance in the Oncology Patient.
Jordan JH; Todd RM; Vasu S; Hundley WG
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1150-1172. PubMed ID: 30092971
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Imaging in Cardio-oncology.
Tong D; Zaha VG
J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Imaging in Oncology Patients in Europe: a Model for Advancement of CV Safety and Development of Comprehensive CV Care.
López-Fernández T
J Cardiovasc Transl Res; 2020 Jun; 13(3):490-494. PubMed ID: 32583314
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive review on cardio-oncology: Role of multimodality imaging.
Chen-Scarabelli C; McRee C; Leesar MA; Hage FG; Scarabelli TM
J Nucl Cardiol; 2017 Jun; 24(3):906-935. PubMed ID: 27225513
[TBL] [Abstract][Full Text] [Related]
8. Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.
Soufer A; Liu C; Henry ML; Baldassarre LA
J Nucl Cardiol; 2020 Aug; 27(4):1210-1224. PubMed ID: 30868378
[TBL] [Abstract][Full Text] [Related]
9. Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities.
Guha A; Armanious M; Fradley MG
Trends Cardiovasc Med; 2019 Jan; 29(1):29-39. PubMed ID: 29910109
[TBL] [Abstract][Full Text] [Related]
10. The Role of Multimodality Cardiac Imaging in Patients Undergoing Cancer Treatment.
Wengrofsky P; Feldman S
Curr Cardiol Rep; 2023 Jan; 25(1):1-8. PubMed ID: 36527535
[TBL] [Abstract][Full Text] [Related]
11. Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction.
Tromp J; Steggink LC; Van Veldhuisen DJ; Gietema JA; van der Meer P
Clin Pharmacol Ther; 2017 Apr; 101(4):481-490. PubMed ID: 28073142
[No Abstract] [Full Text] [Related]
12. Clinical Practice and Research in Cardio-Oncology: Finding the "Rosetta Stone" for Establishing Program Excellence in Cardio-oncology.
Adusumalli S; Alvarez-Cardona J; Khatana SM; Mitchell JD; Blaes AH; Casselli SJ; O'Quinn R; Lenihan DJ
J Cardiovasc Transl Res; 2020 Jun; 13(3):495-505. PubMed ID: 32444945
[TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies.
Florido R; Smith KL; Cuomo KK; Russell SD
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939718
[No Abstract] [Full Text] [Related]
14. Nuclear Imaging for the Assessment of Cardiotoxicity from Chemotherapeutic Agents in Oncologic Disease.
Sreenivasan J; Hooda U; Ranjan P; Jain D
Curr Cardiol Rep; 2021 May; 23(6):65. PubMed ID: 33961140
[TBL] [Abstract][Full Text] [Related]
15. The Role of Biomarkers in Cardio-Oncology.
Ananthan K; Lyon AR
J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
[TBL] [Abstract][Full Text] [Related]
16. Radiation-Associated Cardiac Disease: A Practical Approach to Diagnosis and Management.
Desai MY; Jellis CL; Kotecha R; Johnston DR; Griffin BP
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1132-1149. PubMed ID: 30092970
[TBL] [Abstract][Full Text] [Related]
17. The Role of Cardiac MRI in Animal Models of Cardiotoxicity: Hopes and Challenges.
Park CJ; Branch ME; Vasu S; Meléndez GC
J Cardiovasc Transl Res; 2020 Jun; 13(3):367-376. PubMed ID: 32248349
[TBL] [Abstract][Full Text] [Related]
18. The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.
Russell RR; Alexander J; Jain D; Poornima IG; Srivastava AV; Storozynsky E; Schwartz RG
J Nucl Cardiol; 2016 Aug; 23(4):856-84. PubMed ID: 27251147
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
Narayan HK; French B; Khan AM; Plappert T; Hyman D; Bajulaiye A; Domchek S; DeMichele A; Clark A; Matro J; Bradbury A; Fox K; Carver JR; Ky B
JACC Cardiovasc Imaging; 2016 Oct; 9(10):1131-1141. PubMed ID: 27085442
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease.
Heckmann MB; Reinhardt F; Finke D; Katus HA; Haberkorn U; Leuschner F; Lehmann LH
Circ Cardiovasc Imaging; 2020 Sep; 13(9):e010628. PubMed ID: 32912030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]